We are live on ! Find out more
OGEN icon

Oragenics

7 hedge funds and large institutions have $20.2M invested in Oragenics in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more capital invested

Capital invested by funds: $15.1M → $20.2M (+$5.11M)

0% less ownership

Funds ownership: 0%0% (-0%)

30% less funds holding

Funds holding: 107 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
Increased
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q2 2015 in Review

7 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2015, worth a combined $20.2M — up 34% from $15.1M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of OGEN and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Janney Montgomery Scott, cutting an estimated $18.2K.

  • 7 institutional investors held Oragenics (OGEN) as of Q2 2015, down from 10 in Q1 2015.
  • Funds reported $20.2M of Oragenics stock for Q2 2015, up 34% quarter-over-quarter.
  • 0 funds opened new Oragenics positions in Q2 2015 and 3 closed out, a net change of -3 holders.
  • The largest Oragenics seller in Q2 2015 was Janney Montgomery Scott, an estimated $18.2K sold.

Based on aggregated 13F filings for Q2 2015.